Assessing visual perception difficulties in stroke survivors
Accuracy and Utility of the Oxford Visual Perception Screening (OxVPS), a Screening for Visual Perception Difficulties in Stroke Survivors
Durham University · NCT05981482
This study is testing a new tool to see if it can help identify visual perception problems in stroke survivors receiving rehabilitation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Durham University (other) |
| Locations | 3 sites (Abingdon and 2 other locations) |
| Trial ID | NCT05981482 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of the Oxford Visual Perception Screening (OxVPS) tool in identifying visual perception difficulties among stroke survivors. Participants will complete the OxVPS alongside a gold standard assessment to determine the accuracy of the new tool. The study will involve stroke patients recruited from rehabilitation units in the North East of England and Oxfordshire, who will undergo various validated screening tests. Data on stroke details and demographics will also be collected to assess the representativeness of the sample.
Who should consider this trial
Good fit: Ideal candidates are stroke survivors diagnosed within the last six weeks who can understand and follow simple instructions.
Not a fit: Patients who are unable to concentrate for 15 minutes or have insufficient understanding of English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification of visual perception issues in stroke survivors, enhancing rehabilitation strategies.
How similar studies have performed: While the approach of using the OxVPS tool is relatively novel, similar studies have shown the importance of accurate screening in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage). * Within 6 weeks of confirmed stroke. Exclusion Criteria: * Insufficient understanding of English * Clinical concerns that patient is unable follow simple instructions. * Clinical concerns that patient is unable to concentrate for 15 minutes. * No capacity to provide informed consent.
Where this trial is running
Abingdon and 2 other locations
- Abingdon Community Hospital — Abingdon, United Kingdom (RECRUITING)
- Bishop Auckland Hospital — Bishop Auckland, United Kingdom (RECRUITING)
- Queen Elizabeth Hospital — Gateshead, United Kingdom (RECRUITING)
Study contacts
- Principal investigator: Kathleen Vancleef, PhD — Durham University
- Study coordinator: Kate Cowen, PhD
- Email: kate.cowen@durham.ac.uk
- Phone: 441913343275
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Visual Perception